RESUMO
Total serum IgE, and Strongyloides-specific IgG and IgA antibodies were studied in 27 patients with parasitologically proven strongyloidiasis. Clinical manifestations in this case series were investigated by a retrospective study of the patient's records. Total serum IgE levels were elevated (greater than 250 IU/ml) in 59% of the patients (mean concentration = 1364 IU/ml). Parasite-specific IgG and IgA antibodies were detected by ELISA in the serum of 23 (85.2%) and 21 (77.8%) patients, respectively. Elevated serum IgE and clinical manifestations were not useful indexes of the presence of strongyloidiasis. On the other hand, our results support the view that serologic tests, particularly ELISA for detecting Strongyloides-specific IgG antibodies, can be usefully exploited for diagnostic purposes in strongyloidiasis.
Assuntos
Anticorpos Anti-Helmínticos/análise , Strongyloides stercoralis/imunologia , Estrongiloidíase/diagnóstico , Animais , Ensaio de Imunoadsorção Enzimática , Humanos , Técnicas Imunoenzimáticas , Imunoglobulina A/análise , Imunoglobulina E/análise , Imunoglobulina G/análise , Estudos Retrospectivos , Testes SorológicosRESUMO
A rapid, quantitative enzyme-linked immunosorbent assay (ELISA) for the immunodiagnosis of Chagas' disease is described. The ELISA was standardized with the Falcon assay screening test (F.A.S.T.) system using a purified Trypanosoma cruzi epimastigote fraction (PEF) obtained by ion exchange chromatography. The ELISA technique and an indirect immunofluorescence (IIF) test were used to search for T.cruzi--specific IgG antibodies in 73 patients with chronic Chagas' disease, 58 patients with heterologous infections and 20 healthy controls. The ELISA exhibited 98.6% sensitivity and 98.7% specificity, whereas the sensitivity and specificity of the IIF test were 94.5% and 96.2%, respectively. The excellent performance with regard to sensitivity and specificity, as well as the short assay time make the F.A.S.T. system--based ELISA with PEF a potentially useful tool in screening for antibodies against T. cruzi.
Assuntos
Anticorpos Antiprotozoários/sangue , Doença de Chagas/diagnóstico , Ensaio de Imunoadsorção Enzimática/métodos , Trypanosoma cruzi/imunologia , Animais , Doença de Chagas/sangue , Doença de Chagas/imunologia , Humanos , Fatores de TempoRESUMO
A retrospective study of laboratory records in a 400-bed university hospital in Campinas city, SP (Southeastern Brazil) suggests that infection by Strongyloides stercoralis is widespread in the region. A prevalence of 10.81% was found in 37,621 stool specimens examined in a two-year period. Parasite-specific IgG antibodies were measured by ELISA in sera from 90 patients with strongyloidiasis. The ELISA detected antibody in 76 (84.44%) patients, indicating that serodiagnostic tests may be helpful in screening patients for strongyloidiasis.